Health Discovery Corp. Watch

from 8-K 3 pages January 23, 2017 via Email

from 8-K 3 pages 1. I Will Take No Cash Salary or Stock Option Compensation. 2. the 1,500,000 Director Options Awarded to Me on July 25, 2013 to Purchase Hdc Stock at Market Price of $0.027 Have Been Reassigned to the Company So That They Can Be Used for Better Purposes Such as Raising Capital and/or Compensating Our Workers. 3. I Will Not Seek Reimbursement for My Time or Expenses as They Relate to Me Carrying Out the Duties of Interim Chief Executive Officer

from 10-Q 9 pages Non-Qualified Stock Option Award of Health Discovery Corporation

from 10-K 2 pages As You Are Aware, the Agreement Was Entered Into for the Purpose of an Orderly Transition of Management Duties, Assistance With Special Projects, and the Successful Completion and Commercialization of the Retinalyze Partnership With Doctors Optimal. the Following Is a Non-Exhaustive List of Ways in Which Your Performance Under the Agreement Has Not Complied With Commercially Reasonable Performance Standards or the Terms of the Agreement

from 10-K 9 pages Employment Agreement

from 8-K 2 pages In Addition, You Are Further Notified That Your Performance Under the Agreement Does Not Comply With Commercially Reasonable Performance Standards or the Terms of the Agreement. as You Are Aware, the Agreement Was Entered Into for the Purposes of an Orderly Transition of Management Duties, Assistance With Special Projects, and the Successful Completion and Commercialization of the Retinalyze Partnership With Doctors Optimal. in Particular: 1. Retinalyze. You Have Failed to Roll-Out the Project Effectively, Thereby Delaying Progression of Profitability for the Company. You Have Failed to Take Initiative and Provide Continuous Leadership to the Project or Set and Enforce Appropriate Performance Standards, Task Lists and Deadlines

from 8-K 4 pages October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC Re: Consulting Agreement

from 10-Q 3 pages September 28, 2012 Stafford O’kelly Abbott Molecular via Email /S/ Stephen D. Barnhill, M.D. Stephen D. Barnhill, M.D. Chairman and Chief Executive Officer Health Discovery Corporation

from 10-Q 4 pages October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC 2 Springfield Place Savannah, Ga 31411 Re: Consulting Agreement

from 10-Q 11 pages Introduction

from 8-K 31 pages Master License Agreement

from 10-Q 2 pages First Amendment to the License Agreement

from 10-K 1 page March 28, 2011 Stephen D. Barnhill, M.D. 2 Springfield Place Savannah, Georgia 31411 Re: Month-To-Month Extension of Employment Agreement Dear Dr. Barnhill: Reference Is Made to Your Employment Agreement Dated as of August 15, 2008 (The “Agreement”). as You Are Aware, the Agreement Had an Original Term of Two Years and Expired on August 15, 2010

from 10-Q/A 34 pages Settlement and Release Agreement

from S-1 22 pages Release Agreement

from 10-Q 14 pages Settlement and Release Agreement

from 10-Q 13 pages Confidential Portions of This Document Have Been Omitted Pursuant to a Request for Confidential Treatment and Filed Separately With Securities and Exchange Commission Settlement and Release Agreement

from 10-K 1 page November 25, 2009 the Foregoing Is Agreed and Acknowledged by Health Discovery Corporation By: /S/ R. Scott Tobin Name: R. Scott Tobin Title: President and General Counsel Authorized Representative

from 10-K 4 pages Amendment to License Agreement

from 10-K 22 pages License Agreement